Extracellular Vesicle Surface Markers In Acute Cerebrovascular Syndromes.

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Stroke, TIA, Stroke-mimics, Stroke Biomarkers
Interventions
DIAGNOSTIC_TEST

Extracellular vescicles (EV) analysis

"The patients undergo a blood sample for EV analyses: EVs will be characterized by nanoparticle tracking analysis, western blot, bead-based flow cytometry (direct and inverse approach), and ELISA.~We will evaluate diameter and concentration of serum nanoparticles (NPs) by nanoparticle tracking analysis (NTA) using NanoSight LM10. Western Blot analysis will be performed on protein lysate after EV immuno-capture (using beads covered with antibodies against EV specific tetraspanins, CD9, CD63 and CD81). EV profiling will be performed using a standardized multiplex bead-based flow cytometric assay, using MACSPlex Human Exosome Kit (Miltenyi Biotec; Bergisch Gladbach, Germany), as previously described. 22 The detection of 37 different surface antigens commonly expressed on EV membrane (including markers from activated platelets, endothelium, and inflammatory cells) will be simultaneously performed."

Trial Locations (1)

CH-6900

RECRUITING

Neurocenter of Southern Switzerland, Ospedale Civico, Lugano

All Listed Sponsors
lead

Ospedale Civico, Lugano

OTHER_GOV